HEALTHTRUST INC THE HOSPITAL CO
10-Q, 1995-01-17
GENERAL MEDICAL & SURGICAL HOSPITALS, NEC
Previous: FIRST PRAIRIE MUNICIPAL BOND FUND /, 485BPOS, 1995-01-17
Next: STAR FUNDS, 24F-2NT, 1995-01-17



FORM 10-Q

SECURITIES AND EXCHANGE COMMISSION
Washington, DC  20549

QUARTERLY REPORT UNDER SECTION 13 or 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934


For quarter ended November 30, 1994


Commission file number 001-10915


Healthtrust, Inc. - The Hospital Company
(Exact name of registrant as specified in its charter)


         Delaware                       62-1234332      
(State or other jurisdiction of         (IRS Employer
 incorporation or organization)      Identification No.)


     4525 Harding Road
     Nashville, Tennessee                      37205       
(Address of principal executive             (Zip Code)
 offices)


                    (615) 383-4444                      
Registrant's telephone number, including area code

                    Not Applicable                       
Former name, former address and former fiscal year, if changed
since last report.

Indicate by check mark whether the registrant (1) has filed all
reports required to be filed by Section 13 or 15 (d) of the
Securities Exchange Act of 1934 during the preceding 12 months
(or for such shorter periods that the registrant was required to
file such reports), and (2) has been subject to such filing
requirements for the past 90 days.
Yes X   No     

Indicate the number of shares outstanding of each of the issuer's
classes of common stock, as of the latest practical date.

Common  Stock, $.001 Par Value - 90,895,540 shares as of December
31, 1994.


INDEX

HEALTHTRUST, INC. - THE HOSPITAL COMPANY



PART I.   FINANCIAL INFORMATION                          Page

Item 1.   Financial Statements (Unaudited)

          Condensed consolidated balance sheets--
          November 30, 1994 and August 31, 1994            3

          Condensed consolidated statements of 
          operations--three months ended November 30, 
          1994 and 1993                                    4

          Condensed consolidated statements of
          cash flows--three months ended November 30, 
          1994 and 1993                                    5

          Notes to condensed consolidated 
          financial statements                             6

Item 2.   Management's Discussion and Analysis of       7-11
          Financial Condition and Results of 
          Operations     


PART II.  OTHER INFORMATION

Item 6.   Exhibits and Reports on Form 8-K                12



SIGNATURES                                                13


PART I.  FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS

HEALTHTRUST, INC. - THE HOSPITAL COMPANY
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)
(Dollars in thousands)

                                                     November 30,     August 31
                                                         1994           1994
CURRENT ASSETS
   Cash and cash equivalents                        $     94,783    $   92,327
   Accounts receivable, less allowances for
      doubtful accounts of  $179,050 and  $175,838       595,139       549,554
   Supplies                                               87,021        86,576
   Other current assets                                  113,092       113,752
   TOTAL CURRENT ASSETS                                  890,035       842,209


PROPERTY, PLANT AND EQUIPMENT                          3,019,994     2,990,559
   Less accumulated depreciation                         780,266       736,863
                                                       2,239,728     2,253,696


EXCESS OF PURCHASE PRICE OVER NET ASSETS ACQUIRED        743,514       736,189
OTHER ASSETS                                             134,188       135,188
                                  TOTAL ASSETS        $4,007,465    $3,967,282


CURRENT LIABILITIES
   Accounts payable                                 $    118,772    $  153,821
   Other current liabilities                             407,533       405,244
                      TOTAL CURRENT LIABILITIES          526,305       559,065

LONG-TERM DEBT                                         1,741,921     1,740,872
DEFERRED INCOME TAXES                                     91,186        91,230
DEFERRED PROFESSIONAL LIABILITY RISKS                    224,688       215,503
OTHER LIABILITIES                                        347,421       335,008


STOCKHOLDERS' EQUITY
   Common Stock, $.001 par value; 400,000,000
   shares authorized, 90,722,600 and 90,733,447
   shares issued and outstanding                              91            91
   Paid-in capital                                     1,022,340     1,021,929
   Retained earnings                                      53,513         3,584
                          STOCKHOLDERS' EQUITY         1,075,944     1,025,604

    TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY      $  4,007,465    $3,967,282


See accompanying notes.



HEALTHTRUST, INC. - THE HOSPITAL COMPANY
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
(Dollars in thousands, except per share data)

                                           Three Months Ended November 30
                                                1994             1993
Net operating revenue                       $  969,924       $  622,095
Costs and expenses:
  Hospital service costs:
     Salaries and benefits                     374,748          232,263
     Supplies                                  129,108           87,990
     Fees                                      103,988           64,716
     Other expenses                            102,380           65,740
     Bad debt expense                           64,572           43,590
                                               774,796          494,299

  Depreciation and amortization                 56,080           34,620
  Interest                                      40,458           21,555
  Pension expense                               16,357           10,218
  Other income (net)                            (3,694)          (5,450)
                                               883,997          555,242

     INCOME BEFORE MINORITY INTERESTS
     AND INCOME TAXES                           85,927           66,853

Minority interests                               2,013            1,442

     INCOME BEFORE INCOME TAXES                 83,914           65,411

Income tax provision                            33,985           26,559

     NET INCOME                             $   49,929       $   38,852

Net income per share                        $     0.54       $     0.46

Shares used in computation of net
  income per share                          92,633,566       84,426,187


See accompanying notes.



HEALTHTRUST, INC. - THE HOSPITAL COMPANY
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
(Dollars in thousands)

                                               Three Months Ended November 30
                                                     1994             1993
OPERATING ACTIVITIES
  Net income                                     $   49,929        $   38,852
  Adjustments to reconcile net
    income to net cash provided
    by operating activities:
     Depreciation                                    49,788            32,462
     Amortization                                     6,292             2,158
     Non-cash insurance expense                       1,881             5,120
     Pension expense                                 16,357            10,218
     Increase in accounts and agency
       receivables                                  (45,104)          (21,212)
     Decrease in accounts payable and
       accrued liabilities                          (37,602)          (47,244)
     Other                                            1,089            (1,860)

NET CASH PROVIDED BY OPERATING ACTIVITIES            42,630            18,494

INVESTING ACTIVITIES
  Purchases of property, plant and equipment        (38,164)          (34,318)
  Proceeds from sales of property, plant
    and equipment                                     2,344            96,208
  Other                                              (8,765)             (321)

NET CASH PROVIDED BY (USED IN) INVESTING
  ACTIVITIES                                        (44,585)           61,569

FINANCING ACTIVITIES
  Principal payments on long-term debt              (51,000)          (65,000)
  Proceeds from long-term borrowings                 55,000                 -
  Other                                                 411             1,007

NET CASH PROVIDED BY (USED IN) FINANCING
  ACTIVITIES                                          4,411           (63,993)

INCREASE IN CASH AND CASH EQUIVALENTS                 2,456            16,070

  Cash and cash equivalents at beginning of period   92,327           151,346

CASH AND CASH EQUIVALENTS AT END OF PERIOD        $  94,783        $  167,416

Cash paid during the period for:
  Interest                                        $  63,184        $   41,232
  Income taxes                                        3,326            26,544


See accompanying notes.



HEALTHTRUST, INC. - THE HOSPITAL COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)


Basis of Presentation

The accompanying unaudited condensed consolidated financial
statements have been prepared in accordance with generally
accepted accounting principles for interim financial information
and with the instructions to Form 10-Q and Article 10 of
Regulation S-X.  Accordingly, they do not include all of the
information and footnotes required by generally accepted
accounting principles for complete financial statements.  In the
opinion of management, all adjustments (consisting of normal
recurring accruals) considered necessary for a fair presentation
have been included.  All significant intercompany transactions
have been eliminated in consolidation.  Operating results for the
three months ended November 30, 1994 are not necessarily
indicative of the results that may be expected for the fiscal
year ending August 31, 1995.  For further information, refer to
the consolidated financial statements and footnotes thereto for
the year ended August 31, 1994 (included in the Company's Annual
Report on Form 10-K).

Income Per Share

Income per share has been computed by dividing the net income for
each period by the weighted average number of shares and share
equivalents outstanding during the applicable period, adjusted
for stock splits.

Fully diluted per share data is not presented since the effect
would dilute earnings per share by less than three percent (3%).

Proposed Merger With Columbia/HCA Healthcare Corporation

On October 4, 1994, the Company and Columbia/HCA Healthcare
Corporation jointly announced the signing of a definitive merger
agreement under which the Company's shareholders will receive
0.88 shares of Columbia common stock in exchange for each share
of Healthtrust common stock they hold.  The proposed transaction
is expected to be accounted for as a pooling of interests.

The completion of the transaction is subject to the approval of
the shareholders of both companies and regulatory approvals.  The
shareholders meetings to vote on the proposed merger transaction
are scheduled to be held on February 28, 1995.


ITEM 2.   MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND RESULTS OF OPERATIONS


RESULTS OF OPERATIONS

                                   
SELECTED OPERATING STATISTICS                          
(dollars in millions)                             

Same Hospitals Operating Data (1): 
               
                                   
                              Three Months Ended            
                           November 30,  November 30,  

                                   1994             1993       %Increase

Number of Hospitals                  77               77
Gross Revenue:                     
     Inpatient                $   667.9         $  626.4           6.6%
     Outpatient               $   360.4         $  313.0          15.1%
Net Operating Revenue         $   623.6         $  587.9           6.1%
Hospital Service Costs        $   479.0         $  460.7           4.0%
Admissions                       70,784           67,177           5.4%
Adjusted Admissions             108,981          100,749           8.2%
Patient Days                    345,480          345,106           0.1%
Adjusted Patient Days           531,908          517,576           2.8%
Average Length of Stay (days)      4.88             5.14
Occupancy Rate                      38%              39%
Operating Margin                  23.2%            21.6%
                                   
                                   
                                   
(1)  The results of operations applicable to hospital
acquisitions and dispositions have been excluded.
                                   
          

General

The Company continues to experience gross and net operating
revenue increases and the Company's results of operations
continue to be affected by the trend toward certain services
being performed more frequently on an outpatient basis.  The
Company has been able to achieve increases in net operating
revenue due to the higher utilization of outpatient and ancillary
services, general price increases and an increased severity of
illness for the patients admitted.  Although the Company's net
operating revenue has grown in each period, the impact of price
increases and increases in patient acuity have been partially
offset by the increasing proportion of revenue derived from fixed
payment sources, including Medicare and Medicaid (approximately
45% and 43%, for the quarters ended November 30, 1994 and 1993,
respectively, of the Company's net operating revenue was related
to Medicare and Medicaid patients).  

The growth in outpatient services is expected to continue as
procedures currently being performed on an inpatient basis become
available on an outpatient basis through continuing advances in
pharmaceutical and medical technologies.  The redirection of
certain procedures to an outpatient basis has also been
influenced by pressures from payors to direct certain procedures
from inpatient care to outpatient care.  While the Company
expects the growth in outpatient services to continue, the rate
of increase is expected to decline.

The Company expects Medicare and Medicaid revenue to continue to
increase due to the general aging of the population and the
expansion of state Medicaid programs.  The Medicare program
reimburses the Company's hospitals primarily based on established
rates that are dependant on each patient's diagnosis, regardless
of the provider's cost to treat the patient or the length of time
the patient stays in the hospital.  The Medicare program's
established rates are indexed for inflation annually, but these
increases have historically been less than both the actual
inflation rate and the Company's increases to its standard
charges.  

Insurance companies, government programs (other than Medicare)
and employers purchasing health care services for their employees
are negotiating the amounts they will pay health care providers,
rather than paying the providers standard prices.  This leads to
these purchasers of health care services becoming managed care
payors, similar to HMO's and PPO's, in virtually all markets and
making it increasingly difficult for providers to maintain their
historical net revenue growth trends.

The Congress is currently reviewing various proposals for
comprehensive health care reform.  The reform proposals contain
coverage guarantees, benefits standards and cost control
mechanisms.  The Company cannot predict what reforms the Congress
will adopt, when such reforms will be implemented or the
resulting implications for providers, at this time.  However, the
Company believes that the delivery of primary care, emergency
care, obstetrical services and rehabilitative services, on a
local basis, to rural and suburban markets will be an integral
component of any strategy for controlling health care costs and
the Company believes it is well positioned to provide these
services.  


The Company acquired EPIC  Holdings, Inc. (EPIC), which owned 34
hospitals and various related healthcare entities, and three
other hospital facilities during 1994.  These acquisitions were
made during the third and fourth quarters of fiscal 1994,
therefore the results of operations of these acquired facilities
are included in consolidated operations for the quarter ended
November 30, 1994, but are not included for the quarter ended
November 30, 1993.

Three Months Ended November 30, 1994 and 1993

Net operating revenue for the Company's hospitals for the three 
months ended November 30, 1994, increased 55.9% (14.2% excluding
EPIC) to $969.9 million, while same hospitals net operating
revenue increased 6.1%.  Gross revenue during the three months
ended November 30, 1994, increased 59.1% (15.8% excluding EPIC)
due to a 73.3% increase (23.3% excluding EPIC) in gross
outpatient revenue and a 49.9% increase (12.0% excluding EPIC) in
gross inpatient revenue.  On a same hospitals basis, gross
revenue increased 9.4% compared to the prior year period, due to
a 15.0% increase in gross outpatient revenue and a 6.6% increase
in gross inpatient revenue.  In each case, gross revenue grew
faster than net operating revenue, primarily because the patient
day mix became more heavily weighted  to Medicare, Medicaid and
specialty unit patients (for which reimbursement rate increases
have been less than implemented price increases) and increased
utilization by managed care programs.

Costs of hospital services (salaries and benefits, fees,
supplies, bad debt expense and other expenses) for the three
months ended November 30, 1994 increased 56.7%.  The 55.9%
increase in net operating revenue and 56.7% increase in the costs
of hospital services resulted in the operating margin decreasing
from 20.5% for the three months ended November 30, 1993 to 20.1%
for the 1994 period.  Salaries and benefits, the largest
component of hospital services, increased from 37.3% to 38.6% of
net operating revenue due to higher than average expense at the
facilities acquired during the third and fourth quarters of
fiscal 1994.  Supplies expense decreased from 14.2% of net
operating revenue for the three months ended November 30, 1993 to
13.3% of net operating revenue for the 1994 period, reflecting
the benefits from the Company's efforts to standardize supplies
and consolidate vendors.  Bad debt expense declined from 7.0% to
6.7% of net operating revenue for the three months ended November
30, 1994.

Interest expense increased from $21.6 million to $40.5 million
for the three months ended November 30, 1994, due primarily to
the additional debt incurred to finance the acquisition of EPIC
and the other fiscal 1994 acquisitions.

Income before income taxes increased $18.5 million, due primarily
to the net effect of the $67.3 million increase in net operating
revenue less hospital service costs and $46.5 million increase in
depreciation, amortization, interest, and pension expenses.

The Company's combined federal and state effective tax rate was
40.5% for the three months ended November 30, 1994 and 40.6% for
the 1993 period.

The Company continues to generate significant levels of cash
flows from operating activities, $42.6 million for the three
months ended November 30, 1994 and $18.5 million for the 1993
period.  Although net income increased by $11.1 million,
increases in depreciation and amortization resulted in cash flows
from operations increasing by $24.1 million.



Liquidity and Capital Resources

Healthtrust ended the first quarter of fiscal 1995 in its
strongest financial position:  cash totaled $94.8 million; total
assets reached $4.01 billion; stockholders' equity climbed to
$1.08 billion; and debt as a percentage of total capital was at
61.8%.

Cash provided from operations continued to satisfy all of the
Company's working capital, capital expenditure (excluding EPIC
and other facility acquisitions) and debt principal payment
requirements.  

Management believes that, based upon its analysis of the
Company's financial condition, the cash flow generated from
operations in the future should provide sufficient liquidity to
meet all cash requirements for at least the next year without
substantial additional borrowings.  In addition, the Company
believes, based on current internal long-term projections of
future results of operations, that it will be able to satisfy its
current and expected obligations as they become due without
incurring substantial additional indebtedness, and that
satisfaction of such obligations will not prevent the Company
from meeting liquidity requirements for operations and capital
expenditures.  However, there can be no assurance that future
developments in the health care industry or general economic
trends will not adversely affect the Company's operations or its
ability to meet such obligations.

During April 1994, the Company entered into a credit agreement
with the Bank of Nova Scotia, acting as administrative agent for
the lenders (the "1994 Credit Agreement").  The 1994 Credit
Agreement provides for an aggregate of up to $1.2 billion in
credit available to the Company.  Loans under the 1994 Credit
Agreement bear interest at fluctuating rates, as selected by the
Company at specified times, equal to either (i) an alternate base
rate (the higher of the Bank of Nova Scotia's base rate for
dollar loans or the Federal Funds rate plus 50 basis points)plus
50 basis points or (ii) LIBO plus 150 basis points.

At November 30, 1994, the Company had outstanding $394 million of
term loans, $277 million of delayed term loans and $80 million 
of revolving loans under the 1994 Credit Agreement.  At November
30, 1994, the Company had approximately $428 million of credit
available under the 1994 Credit Agreement.

During 1994, the Company spent $221 million (excluding the EPIC
and other facility acquisitions) for capital expenditures,
primarily to renovate and add new equipment and technology to
existing facilities.  The Company intends to continue to invest
in its existing facilities and in new facilities within its
existing health care business and capital expenditures for fiscal
1995 are expected to be approximately $300 million.  The Company
may seek to sell certain of its hospitals from time to time. 
Management does not consider the sale of any assets to be
necessary to repay the Company's indebtedness or to provide
working capital.  The Company's cash, cash expected to be
generated from operations and  available sources of capital are
believed by management to be adequate to finance its planned
future growth.

The Company receives payment for services rendered from federal
and state agencies (under the Medicare, Medicaid and Champus
programs), private insurance carriers, employers, managed care
programs and patients.  During the three months ended November
30, 1994, approximately 45% of the Company's net operating
revenue related to patients participating  in the Medicare and
Medicaid programs.  The Company recognizes that revenue and
receivables from government agencies are significant to the
Company's operations, but the Company does not believe that there
are any significant credit risks associated with these government
agencies.  The Company does not believe that there are any other
significant concentrations of  revenue from any particular payor
that would subject the Company to any significant credit risks in
the collection of its accounts receivable.

The Company is primarily self-insured for professional and
general liability risks.  The unfunded reserve for professional
and general liability risks was $246.2 million at November 30,
1994.  Payments of professional and general liability claims
aggregated $13.4 million for the  three months ended November 30,
1994.  The Company does not believe that the payment of these
self-insured risks will have any significant impact on the
Company's liquidity or working capital.


PART II.  OTHER INFORMATION


ITEM 6.   EXHIBITS AND REPORTS ON FORM 8-K

     (a)  The following exhibits are included herein:
          (11) Statement re:  Computation of Earnings Per       
               Share
          (27) Financial Data Schedule (included only in filings
               under the EDGAR system)

     (b)  The Company filed a report on Form 8-K dated October 4,
          1994, announcing the signing of a definitive agreement
          between the Company and Columbia/HCA Healthcare Corp.
          to merge in a tax- free, stock-for-stock transaction. 
          A copy of the press release issued by the Company was
          included in the report.




     SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned thereunto duly authorized.

Healthtrust, Inc. - The Hospital Company
(Registrant)


January 17, 1995    /S/ R. Clayton McWhorter                  
    Date                R. Clayton McWhorter
                         Chairman of the Board,
                         Chief Executive Officer and                       
                         President


January 17, 1995    /S/ Kenneth C. Donahey                    
    Date                Kenneth C. Donahey
                         Senior Vice President and
                         Controller
                         Chief Accounting Officer



HEALTHTRUST, INC. - THE HOSPITAL COMPANY

Exhibit 11 - STATEMENT RE:  COMPUTATION OF EARNINGS PER SHARE
Three Months Ended November 30, 1994 and 1993
(Dollars in thousands, except per share data)




                                              Three Months Ended November 30
                                                 1994                  1993
Primary:

  Weighted average shares outstanding        90,671,526             81,097,606
  Net effect of dilutive warrants               695,092              2,610,014
  Net effect of dilutive stock options        1,266,948                718,567
  Total shares and share equivalents         92,633,566             84,426,187

  Net income                                $    49,929            $    38,852

  Net income per share                      $      0.54            $      0.46

Fully Diluted:

  Weighted average shares outstanding        90,671,526             81,097,606
  Net effect of dilutive warrants               695,092              2,633,083
  Net effect of dilutive stock options        1,266,948                764,757
  Total shares and share equivalents         92,633,566             84,495,446

  Net income                                $    49,929            $    38,852

  Net income per share                      $      0.54            $      0.46

WARNING: THE EDGAR SYSTEM ENCOUNTERED ERROR(S) WHILE PROCESSING THIS SCHEDULE.

<TABLE> <S> <C>

<ARTICLE> 5
<CIK> 0000826490
<NAME> HEALTHTRUST, INC - THE HOSPITAL COMPANY
<MULTIPLIER> 1000
       
<S>                             <C>
<PERIOD-TYPE>                   QTR-1
<FISCAL-YEAR-END>                          AUG-31-1995
<PERIOD-END>                               NOV-30-1994
<CASH>                                           94783
<SECURITIES>                                         0
<RECEIVABLES>                                   774189
<ALLOWANCES>                                    179050
<INVENTORY>                                      87021
<CURRENT-ASSETS>                                890035
<PP&E>                                         3019994
<DEPRECIATION>                                  780266
<TOTAL-ASSETS>                                 4007465
<CURRENT-LIABILITIES>                           526305
<BONDS>                                        1741921
<COMMON>                                            91
                                0
                                          0
<OTHER-SE>                                     1075853
<TOTAL-LIABILITY-AND-EQUITY>                   4007465
<SALES>                                              0
<TOTAL-REVENUES>                                969924
<CGS>                                                0
<TOTAL-COSTS>                                   726581
<OTHER-EXPENSES>                                 54399
<LOSS-PROVISION>                                 64572
<INTEREST-EXPENSE>                               40458
<INCOME-PRETAX>                                  83914
<INCOME-TAX>                                     33985
<INCOME-CONTINUING>                              49929
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     49929
<EPS-PRIMARY>                                      .54
<EPS-DILUTED>                                      .54
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission